Episode 7:
The Cure for What Ails Us
Part II—A Dose of Medicine: Evaluating the State of Play from Therapies to Vaccines

Tony Roth |
Wilmington WealthWise with Tony Roth
45455_WWW_Episode_7_NC.jpg

April 20—Chief Investment Officer Tony Roth speaks with Ofer Levy, MD, PhD, physician-scientist in pediatric infectious diseases, Director of the Precision Vaccines Program at Boston Children’s Hospital, and Professor at Harvard Medical School. Dr. Levy discusses the race to develop therapeutics, including plasma therapies, and when we can expect a viable vaccine.

Listen...


Episode 6:
The Cure for What Ails Us
Part I—What Makes This Virus Different From All Other Viruses?

Tony Roth |
Wilmington WealthWise with Tony Roth
45455_WWW_Episode_6_NC.jpg

April 20—University of Pennsylvania microbiologist Susan Weiss, PhD, co-director of the Center for Research on Coronaviruses and Other Emerging Pathogens, joins Chief Investment Officer Tony Roth to discuss the origins of the coronavirus, a field Dr. Weiss has researched for more than four decades. Listen as Dr. Weiss walks us through the biology and epidemiology of COVID-19.

Listen...


Capital Perspectives April 2020

Tony Roth |
Investment Management
Cap-Perspectives-NC.jpg

In the April issue of our monthly flagship publication, we feature:On the Record by Chief Investment Officer Tony Roth, where he sets out the COVID-19-induced market and economic challenges we face: a uniquely devastating recession and oil price collapse—whose effects will hopefully be somewhat cushioned by stimulus on steroids.

Read More...